image_pdfimage_print
14 01, 2022

SB 681

SB 681 modifies telemedicine inclusions by adding secure video conferences and adaptive website questionnaires.

SB 681
14 01, 2022

HB 2123

HB 2123 directs the Insurance Commissioner to determine the duties assigned to the Patient’s Right to Pharmacy Choice Commission. Additionally, the Commissioner may employ actuaries, statisticians, accountants, and attorneys on behalf of the Commission. The measure authorizes the Commission to approve, disapprove, or approve with modifications any filings submitted to it. The Commission may also conduct examinations and investigations of insurance matters within the scope of its authority. The authority to investigate pharmacy benefits managers is transferred from the Insurance Commissioner to the Pharmacy Choice Commission. Other duties transferred to the Pharmacy Choice Commission [...]

HB 2123
14 01, 2022

SB 397

SB 397 directs the Oklahoma Health Care Authority to reimburse a contracted provider for the diagnosis, consultation or treatment of a patient delivered through telemedicine services on the same basis and at least at the rate of reimbursement of other services. The measure also directs the Authority to seek federal approval as needed to implement the provisions of this measure.

SB 397
14 01, 2022

HB 2124

HB 2124 empowers the Pharmacy Choice Commission of the Oklahoma Insurance Department to license pharmacy benefits managers.

HB 2124
14 01, 2022

SB 673

SB 673 modifies the definition of the term telemedicine throughout the bill to be uniform. The measure defines telemedicine as technology-enabled health and care management and delivery systems that extend capacity and access which include synchronous mechanisms, asynchronous mechanisms, remote patient monitoring, and other electronic means that support clinical health care, professional consultation, patient and professional health-related education, public health and health administration. Lastly, the measure provides examples of synchronous and asynchronous mechanisms used in the definition.

SB 673
14 01, 2022

HB 2549

An Act relating to pharmacy; defining terms; providing for the substitution of an interchangeable biological product for a prescribed biological product under certain conditions; requiring electronic notice of substitution; providing exceptions; directing State Board of Pharmacy to maintain link of all interchangeable biological products; providing for codification; and providing an effective date.

HB 2549
14 01, 2022

HB 2800

An Act relating to insurance; amending Section 5, Chapter 426, O.S.L. 2019 (36 O.S. Supp. 2020, Section 6962), which relates to compliance review; modifying calculation of certain insured's contribution; defining term; and providing an effective date.

HB 2800
14 01, 2022

SB 468

SB 468 prohibits any insurer from modifying an insured’s coverage of a prescription drug if the prescription drug had been previously preauthorized for coverage by the insurer or was listed on the formulary of the insurer at the time the insured was prescribed the drug, the insured has already received the drug, and a practitioner continues to prescribe the drug to the insured. The policy may be modified if the federal Food and Drug Administration has issued a statement calling into question the clinical safety of the drug or the manufacturer of the drug [...]

SB 468
14 01, 2022

SB 4

SB 4 authorizes a pharmacist to substitute an interchangeable biological product for a prescribed biological product under certain conditions. The measure specifies that the substituted product be determined by the FDA to be interchangeable. The measure also specifies that the prescribing health care provider has not expressed a preference against substitution in writing, verbally or electronically. The pharmacy is required to notify the patient of the substitution. The dispensing pharmacist is required to make an entry into an electronic records system and post the name of the product and the manufacturer. An entry into [...]

SB 4
14 01, 2022

SB 392

SB 392 requires health insurers to provide direct payment or reimbursement to a pharmacist who provides health care services to an individual if the pharmacist is licensed in this state to provide health care services to individuals and if the health benefit policy, contract or agreement of the individual provides for payment or reimbursement of such service(s).

SB 392